Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type
RS Mehta, D Marin, A Alousi, CG Kanakry… - Blood …, 2023 - ashpublications.org
Haploidentical hematopoietic cell transplantation (HCT) with posttransplant
cyclophosphamide (PTCy) graft-versus-host-disease (GVHD) prophylaxis yields a similar …
cyclophosphamide (PTCy) graft-versus-host-disease (GVHD) prophylaxis yields a similar …
[HTML][HTML] Impact of donor age in haploidentical-post-transplantation cyclophosphamide versus matched unrelated donor post-transplantation cyclophosphamide …
RS Mehta, J Ramdial, D Marin, A Alousi… - … and Cellular Therapy, 2023 - Elsevier
Haploidentical hematopoietic cell transplantation (HCT) with post-transplantation
cyclophosphamide (PTCy) graft-versus-host-disease (GVHD) prophylaxis is associated with …
cyclophosphamide (PTCy) graft-versus-host-disease (GVHD) prophylaxis is associated with …
Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation
We compared outcomes of 1461 adult patients with acute lymphoblastic leukemia (ALL)
receiving hematopoietic cell transplantation (HCT) from a haploidentical (n= 487) or …
receiving hematopoietic cell transplantation (HCT) from a haploidentical (n= 487) or …
[HTML][HTML] Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute …
J Sanz, JE Galimard, M Labopin, B Afanasyev… - Journal of Hematology & …, 2021 - Springer
Background There is no information on the impact of donor type in allogeneic hematopoietic
stem cell transplantation (HCT) using homogeneous graft-versus-host (GVHD) prophylaxis …
stem cell transplantation (HCT) using homogeneous graft-versus-host (GVHD) prophylaxis …
Posttransplant cyclophosphamide‐based anti–graft‐vs‐host disease prophylaxis in patients with acute lymphoblastic leukemia treated in complete remission with …
Background Both mismatched unrelated donor (MMUD) and haploidentical (haplo)
transplantation are valid options in patients with high‐risk acute lymphoblastic leukemia …
transplantation are valid options in patients with high‐risk acute lymphoblastic leukemia …
[HTML][HTML] Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a …
Background Non-T-cell depleted haploidentical hematopoietic stem cell transplantation
(HaploSCT) is being increasingly used in acute lymphoblastic leukemia (ALL) with …
(HaploSCT) is being increasingly used in acute lymphoblastic leukemia (ALL) with …
Posttransplant cyclophosphamide versus anti‐thymocyte globulin versus combination for graft‐versus‐host disease prevention in haploidentical transplantation for …
Background The optimal choice for graft‐versus‐host disease (GVHD) prophylaxis in
haploidentical stem cell transplantation (haplo‐SCT) remains debatable. Posttransplant …
haploidentical stem cell transplantation (haplo‐SCT) remains debatable. Posttransplant …
Post-transplantation cyclophosphamide GvHD prophylaxis after hematopoietic stem cell transplantation from 9/10 or 10/10 HLA-matched unrelated donors for acute …
HLA-matching largely contributes to unrelated donor hematopoietic cell transplantation (UD-
HCT) success but, due to the selective deletion of alloreactive T-cells, post-transplantation …
HCT) success but, due to the selective deletion of alloreactive T-cells, post-transplantation …
[HTML][HTML] Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute …
Graft-versus-host disease (GvHD) prophylaxis for unmanipulated haploidentical
hematopoietic cell transplantation includes posttransplant cyclophosphamide (PTCy) and …
hematopoietic cell transplantation includes posttransplant cyclophosphamide (PTCy) and …
The impact of HLA matching on outcomes of unmanipulated haploidentical HSCT is modulated by GVHD prophylaxis
F Lorentino, M Labopin, K Fleischhauer… - Blood …, 2017 - ashpublications.org
Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) with unmanipulated
grafts is increasingly adopted for high-risk acute leukemia, with acute graft-versus-host …
grafts is increasingly adopted for high-risk acute leukemia, with acute graft-versus-host …